In the title compound, C 25 H 21 BrN 2 O 2 , the fused isoxazolidine ring adopts an envelope conformation with the N atom at the flap and the mean plane of the ring makes dihedral angles of 54.37 (12) and 87.32 (13) , respectively, with the adjacent phenyl and benzene rings. The tetrahydropyran ring has a half-chair conformation. In the crystal, molecules are linked into a double-column structure along the b-axis direction through weak C-HÁ Á ÁO and C-HÁ Á Á interactions.
Related literature
For the biological activity of cyanoacrylates, see: Zhang et al. Table 1 Hydrogen-bond geometry (Å , ).
Cg3, Cg4 and Cg5 are the centroids of the C1-C4/C8/C9, C10-C15 and C17-C22 rings, respectively. Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz þ 1; (ii) x; y þ 1; z; (iii) Àx þ 1; Ày; Àz þ 1.
Data collection: APEX2 (Bruker, 2008); cell refinement: SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: PLATON (Spek, 2009); software used to prepare material for publication: SHELXL97.
Comment
Cyanoacrylates and its derivatives have been widely used as agrochemicals (Zhang et al., 2009 ) and an important intermediate in drugs synthesis (Obniska et al., 2005) .
The geometric parameters of the title molecule ( Fig. 1 ) agree well with reported similar structures (Ye et al., 2009; Suresh et al., 2012; Kanchanadevi et al., 2013) . The crystal packing is controlled by weak intermolecular C-H···O and C -H···π (C3-H3···Cg5 ii , C5-H5B···Cg3 i and C22-H22···Cg4 iii ; symmetry codes as in Table 1 ; Cg3, Cg4 and Cg5 are the centroids of the rings defined by the atoms C1-C4/C8/C9, C10-C15 and C17-C22, respectively) interactions.
Experimental
A mixture of (E)-2-[(4-bromo-2-formylphenoxy)methyl]-3-(4-ethylphenyl)acrylonitrile (2 mmol, 0.75 g) and N-phenylhydroxylamine (3 mmol, 0.33 g) in ethanol (10 ml) was refluxed for 6 h. After the completion of the reaction as indicated by TLC, the reaction mixture was concentrated and the resulting crude mass was diluted with water (15 ml) and extracted with ethyl acetate (3 × 15 ml). The combined organic layer was washed with brine (3 × 15 ml) and dried over anhydrous Na 2 SO 4 , solvent was removed under reduced pressure. The crude mass was purified by column chromatography on silica gel (Acme 100-200 mesh), using ethyl acetate-hexane (1:9) to afford the pure compound as a colourless solid in 82% yield and melting point 171-173 °C.
Refinement
H atoms were positioned geometrically (C-H = 0.93-0.98 Å) and refined using riding model with U iso (H) = 1.2U eq (C) or 1.5U eq (C methyl ). The molecular structure of the title compound, with atom labels and 30% probability displacement ellipsoids for non-H atoms.
Computing details

Figure 2
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8-Bromo-3-(4-ethylphenyl)-1-phenyl-3,3a,4,9b-tetrahydro-1H-chromeno[4,3-c]isoxazole-3a-carbonitrile
